As they prepared for their rare disease launch, this emerging biopharmaceutical company leveraged Veeva Compass Patient to perform a comprehensive patient journey analysis, including a deep dive into specialists diagnosing and treating the condition.

Key Customer Challenges

  • Difficulty finding patients in a rare, often misdiagnosed condition
  • Complex and multifaceted patient journey
  • Specialty pharmacy fulfillment that makes it difficult to have full visibility into competitive prescribing

Analysis Objectives

  • Identify disease markers to signal potential for earlier intervention and diagnosis
  • Analyze specialty visits and care team dynamics to inform targeting
  • Continuous access to data for future analysis and tracking opportunities in anticipation of launch

Veeva Approach

Veeva Compass Patient is designed to provide visibility into diagnoses, claims, and prescriptions that are hard to capture with traditional data sources. Designed to support today’s complex therapies, Veeva takes a patient-first approach to building a longitudinally complete data set. Veeva Compass Patient brings together data from health plans, PBMs, payers, retail and specialty pharmacies, switch companies, and more. Data is connected at a patient level using AI prior to de-identification, further driving complete data for complex therapies.

For this analysis, the customer pulled data that included all records over a 5-year period for qualified patients.

Patient Journey Analysis

The patient journey was analyzed in terms of:

  • Treating and diagnosing specialists
  • Referring healthcare providers
  • Diagnosis visits
  • Drug therapy and procedures
  • Elapsed time between interventions

The patient journey can take multiple years to get to the eventual treatment and monitoring phase. Symptoms are similar to those of many other conditions, which results in both underdiagnoses and misdiagnoses. It is critical to understand what dynamics lead to proper diagnosis in order to increase early interventions and speed the path to treatment. The predictors of the undiagnosed patient population are evolving in real time, which requires an iterative data and analytics approach.

Key Findings

In addition to those conditions known to commonly occur among diagnosed patients, the patient journey analysis uncovered a high rate of mood disorders. While mood disorders were included in prior qualitative research with focus groups, the full longitudinal patient history highlighted how meaningful and common this comorbidity is for patients.

Business Impact

By identifying key disease markers, the client developed predictive models to find HCPs treating high-risk patients, allowing for earlier intervention, diagnosis, and treatment.

Finding Key Specialists and Healthcare Providers

By analyzing doctors’ visits along the patient journey, a wide range of specialists were observed. Key specialists varied by the age of the patient, with urologists and nephrologists playing the largest role in diagnosing middleaged patients, significantly greater than patients of other ages. After seeing numerous specialists for a year prior to diagnosis, the referral to a urologist or nephrologist was highly correlated with a correct diagnosis and treatment.

Business Impact

Through expanded HCP segmentation, the customer was able to:

  • Identify key HCPs for earlier, more targeted HCP outreach
  • Better understand referral, diagnosis and treatment patterns by specialty
  • Have a clearer picture of the full treatment team and referral patterns, enabling earlier specialist referrals

Preparing for Launch

The brand’s commercial strategy is built on a better understanding of the full patient journey, as well as specialist referral and diagnosis patterns. As pre-launch planning continues, the brand is focused on speeding up the path to diagnosis by engaging the full treatment team. Using disease markers, the brand is finding HCPs treating at-risk patients to drive to accurate diagnosis faster.

Veeva Compass Patient can be leveraged to support a successful commercial launch.

  • Market landscape analysis
  • Trend and share reporting
  • Advanced patient analytics
  • Customer segmentation and targeting

Using Veeva Compass Patient, the customer was able to successfully define launch KPIs and establish a strong foundation for launch.

More Customer Stories

Data Considerations for a Rare Disease Launch
Watch Webinar
Takeda Maximizes Promotional Effectiveness with Patient Data
Watch Patient Data Video
PharmaEssentia USA Corporation Selects Veeva Data Cloud to Support Launch
Read the Announcement

Interested in learning more about Veeva?